MADOPAR 200/50 Milligram Capsules Hard Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

madopar 200/50 milligram capsules hard

roche products limited - levodopa, benserazide hydrochloride - capsules hard - 200/50 milligram - dopa and dopa derivatives

MADOPAR RAPID 125 Dispersible 125mg tablet bottle Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

madopar rapid 125 dispersible 125mg tablet bottle

roche products pty ltd - levodopa, quantity: 100 mg; benserazide hydrochloride, quantity: 28.5 mg (equivalent: benserazide, qty 25 mg) - tablet, dispersible - excipient ingredients: citric acid; microcrystalline cellulose; magnesium stearate; pregelatinised maize starch - parkinson's disease and parkinsonian symptoms including post-encephalitic and toxic forms, but excluding drug induced parkinsonism.

MADOPAR 125 CAPSULE 125 mg Singapor - Ingliż - HSA (Health Sciences Authority)

madopar 125 capsule 125 mg

roche singapore pte. ltd. - benserazide hcl; levodopa - capsule - 28.5mg - benserazide hcl 28.5mg; levodopa 100mg

MADOPAR ROCHE 125 CAPSULE Malasja - Ingliż - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

madopar roche 125 capsule

roche (malaysia) sdn. bhd. - benserazide hydrochloride; levodopa -

MADOPAR 50/12.5 Milligram Capsules Hard Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

madopar 50/12.5 milligram capsules hard

roche products limited - levodopa benserazide hydrochloride - capsules hard - 50/12.5 milligram

Madopar 100mg/25mg capsules Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 100mg/25mg capsules

roche products ltd - levodopa; benserazide hydrochloride - oral capsule - 100mg ; 25mg

Madopar 200mg/50mg capsules Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

madopar 200mg/50mg capsules

roche products ltd - benserazide hydrochloride; levodopa - oral capsule - 50mg ; 200mg

Madopar 200 mg/50 mg hard capsules Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

madopar 200 mg/50 mg hard capsules

roche products (ireland) ltd - levodopa; benserazide - capsule, hard - 200 mg/50 milligram(s) - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

MADOPAR 50/12.5 Milligram Tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

madopar 50/12.5 milligram tablets

roche products limited - levodopa, benserazide hydrochloride - tablets - 50/12.5 milligram - dopa and dopa derivatives

MADOPAR Capsules Hard 50/12.5 Milligram Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

madopar capsules hard 50/12.5 milligram

roche products ltd - levodopa benserazide hydrochloride - capsules hard - 50/12.5 milligram